血浆衍生品市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00007250
  • Category : Biotechnology
  • Status : Published
  • No. of Pages : 209
Buy Now

[研究报告]血浆衍生品市场预计将从 2022 年的 2988612 万美元增至 2028 年的 5111924 万美元;预计 2022 年至 2028 年间复合年增长率将达到 9.4%。

血浆衍生物是通过分馏循环从显性血浆蛋白中获得的。血浆衍生物含有大量的蛋白质、盐、矿物质、激素、维生素和蛋白酶抑制剂。因此,它们通常用于消灭引发出血性疾病、乙型肝炎、丙型肝炎、甲型血友病、免疫缺陷、低丙种球蛋白血症、乙型血友病和人类免疫缺陷病毒的病毒。

血浆衍生物市场是基于细分市场的关于类型、应用、最终用户和地理位置。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和亚洲。非洲和南方和南方。中美洲。该报告提供了深入的市场信息和分析,强调市场趋势、技术进步和市场动态等参数,以及全球领先市场参与者的竞争格局分析。

血浆衍生品市场:战略洞察

血浆衍生物市场利润丰厚的区域

市场洞察:血浆衍生物市场

在多种治疗中增加免疫球蛋白 G 的使用,为未来几年血浆衍生物市场

免疫球蛋白G(IgG)疗法广泛用于治疗由遗传缺陷引起的免疫系统原发性缺陷。由于人们对 IgG 疗法的认识不断提高,过去几年对 IgG 的需求一直在稳步增长。根据网络荟萃分析(NMA)进行的对照试验,IgG疗法已被批准用于治疗格林巴利病。 (GBS)、慢性炎症性脱髓鞘性多发性神经病(CIDP)、多灶性运动神经病(MMN)和皮肌炎。 IgG 疗法对于治疗重症肌无力和僵人综合症的恶化也有效。此外,它对癫痫、神经脊髓炎和自身免疫性脑炎等自身免疫性疾病也具有令人信服的功效。

  • 2022 年,Grifols 与加拿大血液服务中心签署了一项协议。该协议加速了加拿大免疫球蛋白的自给自足。根据协议,Grifols 将与加拿大血液服务局合作,逐步增加加拿大的血浆供应量,直至 2026 年达到每年 240 万克 Ig 药物的供应量。
  • 2021 年,食品和药物管理局(Cutaquig 经 FDA 批准用于医疗用途。它用作成人和 2 岁及以上儿童患者原发性体液免疫缺陷(PI)的替代疗法。Cutaquig 是一种用于皮下输注的即用型免疫球蛋白溶液。该产品提供 1 g、1.65 g、2 g、3.3 g、4 g 或 8 g 的一次性小瓶包装。
  • 2020 年 8 月,Kedrion Biopharma(意大利)开始改进血浆推断治疗,以治疗 COVID-19 患者 三年半后患者即可获得治疗

很大一部分 IgG 用于免疫学以外的专业,例如肿瘤学、神经学、血液学和风湿学。与所有专业相比,神经病学是全球市场上增长最快的专业。免疫球蛋白G市场的增长归因于其被批准用于治疗慢性炎症性脱髓鞘性多发性神经病(CIDP),其次是其用于淋巴瘤、骨髓瘤和白血病引起的继发性免疫缺陷以及某些免疫抑制疗法,特别是。 B 细胞靶向疗法。因此,IgG 在标签内和标签外处方的多种治疗中的广泛使用将推动未来几年全球对 IgG 的需求。

来自最终的信息用户

基于对于最终用户,全球血浆衍生物市场分为医院、诊所和其他。医院细分市场在 2022 年占据最大的市场份额,预计在预测期内复合年增长率最高。预计住院人数的增加以及血管性血友病、免疫缺陷病和血友病患病率的上升将在预测期内推动医院领域的市场增长。此外,新兴国家正在见证对先进医院环境的巨大需求,以解决不断增长的患者数量和日益增长的公共卫生问题。此外,医院还进行各种免疫球蛋白替代疗法,以观察剂量和治疗相关的不良事件,并监测产品的临床结果。医院是提供免疫球蛋白替代疗法的主要中心,这些疗法正在使用新技术开发。在医院接受免疫球蛋白治疗的患者感受到更高的安全性、更密切的随访以及卫生专业人员和专家的支持的优势。因此,医院提供的好处(例如充分的以患者为中心的护理和提供报销服务)预计将在预测期内推动该细分市场的市场增长。

血浆衍生物市场(按最终用户) ; 2022 年和 2028 年

产品发布、并购是全球血浆衍生品市场参与者最常采用的策略之一。部分最新关键产品开发如下:

  • 2022年4月,Grifols宣布完成对天成(德国)医药控股股份公司100%股本的收购。天成(德国)医药控股股份公司是一家德国公司,拥有Biotest AG 89.88%的普通股和1.08%的优先股。公开收购要约 (PTO) 完成并完成收购后,Grifols 控制着 Biotest AG 96.20% 的投票权,并拥有 Biotest AG 69.72% 的股本。

派生来自血浆 –市场细分

根据类型,血浆衍生物市场分为白蛋白、因子VIII、因子IX、免疫球蛋白、超免疫球蛋白等。免疫球蛋白市场进一步细分为 IgG、IgM、IgA、IgD 和 IgE。根据应用,血浆衍生物市场分为血友病、低丙种球蛋白血症、免疫缺陷疾病、冯维勒布兰德病和其他应用。按最终用户划分,市场分为医院、诊所和其他。根据地理位置,血浆衍生品市场分为北美(美国、加拿大和墨西哥)、欧洲(法国、德国、英国、意大利、西班牙和欧洲其他地区)、亚太地区(中国、日本、印度、澳大利亚) 、韩国和亚太其他地区)、中东和亚洲。非洲(沙特阿拉伯、南非、阿拉伯联合酋长国以及中东和非洲其他地区)以及南非和非洲。中美洲(巴西、阿根廷以及中南美洲其他地区)。

公司简介:血浆衍生品市场

  • Grifols, SA
  • SK Plasma Co., Ltd.
  • Fusion Healthcare
  • Biotest AG
  • Green Cross Corp
  • Kedrion
  • LFB SA
  • Octapharma AG
  • CSL 有限公司
  • 武田制药有限公司
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the blood plasma derivative?

Blood plasma is the liquid component of blood where the blood cells are suspended. It contains dissolved proteins (albumins, globulins, and fibrinogen), clotting factors, hormones, and electrolytes. Plasma maintains blood pressure and helps exchange important minerals such as sodium and potassium for maintaining the body's pH balance. Plasma derivatives are products manufactured from human plasma using plasma fractionation techniques. These derivatives include albumin, factor VIII & IX, anti-inhibitor coagulation complex (AICC), and immunoglobulins, including Rh immune globulin, alpha 1-proteinase inhibitor concentrate, and anti-thrombin III.

What are the driving factors for the global blood plasma derivative market across the world?

The factors that are driving the growth of market are increasing prevalence of blood disorders across the world followed by rising geriatric population. However, high cost of blood plasma therapy followed by complicated reimbursement policies are the major factor hampering the growth of the market.

Who are the major players in market the blood plasma derivative market?

The blood plasma derivative market majorly consists of the players such as Grifols, S.A., SK Plasma Co., Ltd., Fusion Healthcare, Biotest AG, Green Cross Corp, Kedrion, LFB S.A., Octapharma AG, CSL Limited, and Takeda Pharmaceutical Company Limited.

Which segment is dominating the blood plasma derivative market?

The blood plasma derivative market is analyzed in the basis of type, application, and end use. Based on type, is segmented into albumin, factor VIII, factor IX, immunoglobulin, hyperimmune globulin, and others. The immunoglobulins segment held the largest share of the blood plasma derivative market size, and it is anticipated to register the highest CAGR.

The List of Companies - Blood Plasma Derivatives Market

  1. Grifols SA
  2. SK Plasma Co Ltd
  3. Octapharma AG
  4. Monobind Inc
  5. Intas Pharmaceuticals Ltd
  6. Fusion Health Care Pvt Ltd
  7. Takeda Pharmaceutical Co Ltd
  8. CSL Behring LLC
  9. LFB SA
  10. Kedrion SpA

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports